Variant report
Variant | esv2001049 |
---|---|
Chromosome Location | chr14:104775050-104775471 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:104768093..104769693-chr14:104774112..104776117,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200327235 | chr14:104775057-104775058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs71421294 | chr14:104775070-104775071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71421295 | chr14:104775073-104775074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554404119 | chr14:104775079-104775080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs71421293 | chr14:104775080-104775081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75419218 | chr14:104775094-104775095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34605784 | chr14:104775095-104775096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574454367 | chr14:104775099-104775100 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35336480 | chr14:104775103-104775104 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs377327097 | chr14:104775116-104775117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370575041 | chr14:104775117-104775118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145443609 | chr14:104775118-104775119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536495203 | chr14:104775119-104775120 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs75633630 | chr14:104775126-104775127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113647618 | chr14:104775140-104775141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs34011777 | chr14:104775141-104775142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34768751 | chr14:104775149-104775150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144201156 | chr14:104775164-104775165 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35289295 | chr14:104775172-104775173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35900257 | chr14:104775187-104775188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34913124 | chr14:104775195-104775196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112883979 | chr14:104775209-104775210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs34800558 | chr14:104775210-104775211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111541557 | chr14:104775212-104775213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374943511 | chr14:104775218-104775219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111805514 | chr14:104775233-104775234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372474415 | chr14:104775241-104775242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142312913 | chr14:104775254-104775255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs138873318 | chr14:104775255-104775256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143070666 | chr14:104775256-104775257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113876120 | chr14:104775257-104775258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs66845612 | chr14:104775258-104775259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573837682 | chr14:104775279-104775280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369496707 | chr14:104775364-104775365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565293595 | chr14:104775368-104775369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75937238 | chr14:104775380-104775381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544570780 | chr14:104775395-104775396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs373770068 | chr14:104775403-104775404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530201241 | chr14:104775413-104775414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372323000 | chr14:104775425-104775426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ependymoma | 20639864 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:104773200-104775200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr14:104774800-104776000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |